New York will receive $61 million from a national settlement with Merck & Co. This will resolve an investigation into the marketing of the painkiller Vioxx. A federal court has accepted Merck’s guilty plea to one misdemeanor count of violating marketing laws. Merck marketed Vioxx as a treatment for rheumatoid arthritis without federal approval for almost three years and, according to the Justice Department, made false statements about its cardiovascular safety. As we know all too well, Vioxx was taken off the market in September 2004 after evidence showed it doubled the risk of heart attack and stroke.
Source: Insurance Journal
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.